Related Experiment Video

Updated: Jun 30, 2025

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

10.9K

Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting

Yuanyuan Zeng1,2,3, Jian Zhao1, Zhengyan Wu4

  • 1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006, Suzhou, China.

NPJ Precision Oncology
|March 24, 2024
PubMed

Insights

Rab27A promotes non-small cell lung cancer (NSCLC) growth and metastasis by mediating exosome secretion and activating the TYK2/STAT/HSPA5 pathway. Inhibiting this axis offers a potential therapeutic strategy for NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Rab27A, a small GTPase, is implicated in exosome secretion and tumorigenesis across various cancers.
  • Understanding Rab27A's role in non-small cell lung cancer (NSCLC) is crucial for advancing oncological research and clinical treatment.

Purpose of the Study:

  • To investigate the function and underlying mechanism of Rab27A in NSCLC.
  • To explore the potential of targeting the Rab27A-mediated pathway for NSCLC therapy.

Main Methods:

  • Investigated Rab27A expression and its regulation by miR-124 in NSCLC.
  • Assessed the impact of Rab27A on tumor proliferation, migration, invasion, and cell motility in vitro and in vivo.
  • Analyzed the role of Rab27A-mediated exosome secretion in IFNα production and subsequent TYK2/STAT/HSPA5 signaling activation.
  • Evaluated the efficacy of the TYK2 inhibitor Cerdulatinib in suppressing the Rab27A-driven pathway.

Main Results:

  • Rab27A is overexpressed in NSCLC and promotes tumor progression.
  • Rab27A enhances NSCLC cell proliferation, migration, invasion, and motility.
  • Rab27A induces IFNα production via exosome secretion, activating the TYK2/STAT/HSPA5 pathway.
  • The TYK2 inhibitor Cerdulatinib effectively suppresses this oncogenic signaling axis.

Conclusions:

  • Rab27A plays a significant role in NSCLC pathogenesis through exosome secretion and downstream signaling.
  • Targeting the Rab27A-IFNα-TYK2/STAT/HSPA5 axis presents a promising therapeutic strategy for NSCLC.
  • Further research into Rab27A inhibitors could lead to novel clinical treatments for NSCLC.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.9K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.3K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.8K